Imaging Biometrics - Grant of Share Options

Imaging Biometrics

07/08/2025 11:22

RNS Number : 4317U

Imaging Biometrics Limited

07 August 2025

 

 

Imaging Biometrics Limited

("IB" or the "Company")

 

Grant of Share Options

 

The Board of Directors of IB approved, at the February board meeting of the Company, the issuance of incentive share option awards ("Options") to key personnel as part of the Company's ongoing strategy to align performance incentives with long-term value creation.

 

The following Options were granted to key non-Board IB staff and service providers:

 

Options Granted
Exercise Price
Vesting Schedule from the date of grant (February 2025)
1,000,000
£0.0145
50% after 1 year and the balance after 2 years
550,000
£0.0145
50% after 1 year; 25 % vests after 2 years; the balance vests after 3 years
Up to 6,000,000
£0.04
1 000 000 vests after 1 year; each remaining tranche of 1 000 000 vests upon a qualifying sale of IB Nimble, but not before the first anniversary of the grant

 

 

All Options held by IB staff are subject to continued employment at the time of vesting.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

 

 

-ENDS-

 

For further information, please contact:

 

IQ-AI Limited
Trevor Brown/Brett Skelly/Dr Musella
Tel: 020 7469 0930
Peterhouse Capital Limited (Financial Adviser and Broker)
Tel: 020 7220 9797

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
STRPRMMTMTTMBMA